Evidence map›Paper›PMID 24506871›Full record

Trial reportCell metabolism2014

Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans.

Paul Lee, Joyce D Linderman, Sheila Smith, Robert J Brychta, Juan Wang, Christopher Idelson, Rachel M Perron, Charlotte D Werner, Giao Q Phan, Udai S Kammula and 4 more

Registry-linked trialOpen access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Cell metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02725879 (Association of Serum Fibroblast Growth Factor 21), which is not on this map. Cited by 416 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
416citing papers in PubMed, 4 pooled it
53.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02725879 completednot on this mapstarted 2015, after this paper: background citation

Association of Serum Fibroblast Growth Factor 21 (FGF-21) Levels With Resting Metabolic Rate (RMR), in Children and Adolescents With Hashimoto's Thyroiditis.

TypeobservationalSponsorAristotle University Of ThessalonikiRan2015 to 2020Enrolled90ConditionsHashimoto Disease
3 · Its place in the literature

Who cites it

416 citing papers in PubMed, 4 syntheses or guidelines pooled it, 794 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Adipocyte-Derived Leptolin Enhances Energy Expenditure and Prevents Obesity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  18. Article
  19. Review
  20. Article

356 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Paul LeeDiabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Joyce D LindermanDiabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Sheila SmithDiabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Robert J BrychtaDiabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Juan WangDiabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Christopher IdelsonDiabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Rachel M PerronDiabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Charlotte D WernerDiabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Giao Q PhanSurgery Branch, National Institutes of Health, Bethesda, MD 20892, USA.
Udai S KammulaSurgery Branch, National Institutes of Health, Bethesda, MD 20892, USA.
Electron KebebewEndocrine Oncology Branch, National Institutes of Health, Bethesda, MD 20892, USA.
Karel PacakNational Cancer Institute and Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
Kong Y ChenDiabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Francesco S CeliDiabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: fsceli@vcu.edu.
National Institutes of Health · US

Funding

Development of obesity and metabolic clinical research programsZIADK071014 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI CHEN, KONG · 2009 to 2025
$12.3M
Genomic and genetic studies of endocrine cancersZIABC011275 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KEBEBEW, ELECTRON · 2010 to 2018
$8.2M
Role of BK-Beta 1 in flow-dependent K+ secretion in the CNTR01DK071014 · NIDDK · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SANSOM, STEVEN · 2007 to 2015
$2.7M
HTS for Detection of deltaF508 CFTR at the Cell SurfaceR01DK071013 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RIORDAN, JOHN R · 2005 to 2007
$747k
Thyroid hormone action on glucose and energy metabolism in vivo studiesZ01DK047057 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI CELI, FRANCESCO S · 2008 to 2008
$481k
Phenotyping studies related to energy balance and obesityZ01DK071013 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI CHEN, KONG · 2008 to 2008
$319k
Development of technologies to support obesity and metabolic researchZ01DK071014 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI CHEN, KONG · 2008 to 2008
$319k
Intramural NIH HHS Z01 DK047057Intramural NIH HHS ZIA BC011275NIDDK NIH HHS R01 DK071013NIDDK NIH HHS R01 DK071014NIDDK NIH HHS Z01-DK047057-02NIDDK NIH HHS Z01-DK071013NIDDK NIH HHS Z01-DK071014NIDDK NIH HHS Z01-DK071044
6 · The paper itself

Abstract

Rediscovery of cold-activated brown adipose tissue (BAT) in humans has boosted research interest in identifying BAT activators for metabolic benefits. Of particular interest are cytokines capable of fat browning. Irisin, derived from FNDC5, is an exercise-induced myokine that drives brown-fat-like thermogenesis in murine white fat. Here we explored whether cold exposure is an afferent signal for irisin secretion in humans and compared it with FGF21, a brown adipokine in rodents. Cold exposure increased circulating irisin and FGF21. We found an induction of irisin secretion proportional to shivering intensity, in magnitude similar to exercise-stimulated secretion. FNDC5 and/or FGF21 treatment upregulated human adipocyte brown fat gene/protein expression and thermogenesis in a depot-specific manner. These results suggest exercise-induced irisin secretion could have evolved from shivering-related muscle contraction, serving to augment brown fat thermogenesis in concert with FGF21. Irisin-mediated muscle-adipose crosstalk may represent a thermogenic, cold-activated endocrine axis that is exploitable in obesity therapeutics development.

Indexed as

AdipocytesAdipokinesAdipose Tissue, BrownAdultExerciseFemaleFibroblast Growth FactorsFibronectinsHumansMaleShiveringYoung AdultAdipokinesfibroblast growth factor 21Fibroblast Growth FactorsFibronectinsFNDC5 protein, human

Identifiers

PMID24506871
PMCPMC7647184
OpenAlexW2163644328

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.